MA49526A - Chimiothérapie anticancéreuse mettant en uvre un composé azabicyco - Google Patents

Chimiothérapie anticancéreuse mettant en uvre un composé azabicyco

Info

Publication number
MA49526A
MA49526A MA049526A MA49526A MA49526A MA 49526 A MA49526 A MA 49526A MA 049526 A MA049526 A MA 049526A MA 49526 A MA49526 A MA 49526A MA 49526 A MA49526 A MA 49526A
Authority
MA
Morocco
Prior art keywords
azabicyco
compound
cancer chemotherapy
chemotherapy
cancer
Prior art date
Application number
MA049526A
Other languages
English (en)
Inventor
Shuichi Ohkubo
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Publication of MA49526A publication Critical patent/MA49526A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39558—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39566—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against immunoglobulins, e.g. anti-idiotypic antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
MA049526A 2017-06-30 2018-06-29 Chimiothérapie anticancéreuse mettant en uvre un composé azabicyco MA49526A (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2017128823 2017-06-30
JP2017177390 2017-09-15
JP2018099931 2018-05-24

Publications (1)

Publication Number Publication Date
MA49526A true MA49526A (fr) 2021-03-24

Family

ID=64741994

Family Applications (1)

Application Number Title Priority Date Filing Date
MA049526A MA49526A (fr) 2017-06-30 2018-06-29 Chimiothérapie anticancéreuse mettant en uvre un composé azabicyco

Country Status (13)

Country Link
US (1) US20200129487A1 (fr)
EP (1) EP3646869A4 (fr)
JP (2) JP7264812B2 (fr)
KR (1) KR102599698B1 (fr)
CN (1) CN110831594A (fr)
AU (1) AU2018291366B2 (fr)
BR (1) BR112019028226A2 (fr)
CA (1) CA3068580A1 (fr)
MA (1) MA49526A (fr)
MX (1) MX2020000150A (fr)
RU (1) RU2020103758A (fr)
TW (1) TW201904573A (fr)
WO (1) WO2019004417A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019004417A1 (fr) * 2017-06-30 2019-01-03 大鵬薬品工業株式会社 Chimiothérapie anticancéreuse mettant en œuvre un composé azabicyco

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2206517T (pt) 2002-07-03 2023-11-07 Tasuku Honjo Composições de imunopotenciação contendo anticorpos anti-pd-l1
BRPI1013999B1 (pt) 2009-07-10 2020-06-02 Taiho Pharmaceutical Co., Ltd. Composto de azabiciclo e um sal deste, produto farmacêutico e composição farmacêutica compreendendo dito composto e uso do mesmo para tratar câncer
ES2848706T3 (es) * 2013-09-30 2021-08-11 Taiho Pharmaceutical Co Ltd Terapia de combinación contra el cáncer usando un compuesto azabicíclico
KR20170113664A (ko) * 2015-02-09 2017-10-12 마드리갈 파마슈티칼스 인코포레이티드 암 치료를 위한 hsp90 억제제 및 pd-1 억제제의 병용 요법
WO2019004417A1 (fr) 2017-06-30 2019-01-03 大鵬薬品工業株式会社 Chimiothérapie anticancéreuse mettant en œuvre un composé azabicyco

Also Published As

Publication number Publication date
AU2018291366A1 (en) 2020-01-23
CA3068580A1 (fr) 2019-01-03
JP2021098726A (ja) 2021-07-01
WO2019004417A1 (fr) 2019-01-03
KR20200021464A (ko) 2020-02-28
JP7264812B2 (ja) 2023-04-25
JPWO2019004417A1 (ja) 2020-05-21
MX2020000150A (es) 2020-07-22
RU2020103758A (ru) 2021-07-30
EP3646869A1 (fr) 2020-05-06
KR102599698B1 (ko) 2023-11-07
BR112019028226A2 (pt) 2020-07-07
TW201904573A (zh) 2019-02-01
US20200129487A1 (en) 2020-04-30
RU2020103758A3 (fr) 2021-10-22
AU2018291366B2 (en) 2022-10-27
CN110831594A (zh) 2020-02-21
JP7319314B2 (ja) 2023-08-01
EP3646869A4 (fr) 2021-03-24

Similar Documents

Publication Publication Date Title
MA47433A (fr) Composé de quinazoline
DK3565712T3 (da) Forbedringer til additiv fremstilling
DK3360864T3 (da) Pyrimidinforbindelse
MA45940A (fr) Composé hétérocyclique
DK3519398T3 (da) Pyridinforbindelse
DK3298027T3 (da) Anthelmintiske depsipeptidforbindelser
DK3186244T3 (da) Dioxolananaloger af uridin til behandling af cancer
DK3612519T3 (da) Phenyl-2-hydroxy-acetylamino-2-methyl-phenyl forbindelser
DK3271435T3 (da) Sammensatte søjlestrukturer
MA50093A (fr) Composé pentacyclique
DK3395821T3 (da) Antitumorforbindelser
MA43275A (fr) Composé de pyranodipyridine
MA45090A (fr) Compositions anticancéreuses
DE112017003214A5 (de) Bohrwerkzeug
DK3347403T3 (da) Polyalkoxyfedtforbindelse
DK3256690T3 (da) Brøndboringsindsprøjtningssystem
IL253276A0 (en) Anticancer compounds
DK3419598T3 (da) Fosfomycinformulering til parenteral administration
MA49880A (fr) Composés anticancéreux
DK3672941T3 (da) Pyridylpyridonforbindelser
DK3173531T3 (da) Indretning til jordundersøgelse
IT201600102119A1 (it) Seminatrice
DK3630729T3 (da) Pyrimidinforbindelse
MA49526A (fr) Chimiothérapie anticancéreuse mettant en uvre un composé azabicyco
DK3672962T3 (da) Morpholinylpyridonforbindelser